Skip to main content
Erschienen in: Comparative Clinical Pathology 1/2016

01.01.2016 | Original Article

Liver function, paraclinical tests, and mortality risk factors in pediatric liver transplant candidates

verfasst von: Naghi Dara, Seyed Mohsen Dehghani, Alireza Safarpour, Masood Sepehrimanesh

Erschienen in: Comparative Clinical Pathology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Liver transplantation has become a well-recognized transplant modality for children with end-stage liver disease. The first indicator to evaluate its efficiency is mortality rate. The aim of this study is to evaluate the complications and mortality of liver disease in children waiting for transplantation and understanding the risk factors that predict liver transplant waiting list death. This is a single-center prospective cohort study of all patient ≤18 years of age with chronic liver disease listed for liver transplantation. We analyzed medical records of 130 children for mortality risk factor. There were 52.3 % boys and 47.7 % girls with mean age of 8.6 ± 6.1 year (range, 3 months–18 year). The most common causes of cirrhosis were biliary atresia (21.5 %). The most common complication while awaiting transplantation was failure to thrive (76.2 %). Up to end of study, 20 patients (15.4 %) died without transplantation, 22 (16.9 %) of them transplanted, and 88 (67.7 %) of patients were alive while waiting for a liver transplantation. Mortality rate and transplantation ratio were 15.4 and 16.9 % with survival time waiting list 67.7 %. Factors which significantly associated with waiting list mortality included encephalopathy (p = 0.006), child score ≥10 (p = 0.036), model for end-stage liver disease (MELD) score ≥20 (p = 0.002), gastrointestinal bleeding (p = 0.004), Na (p = 0.046), and international normalized ratio (INR) (p = 0.018). A pediatric risk factor = (0.715 × Encephalopathy) + (0.152 × INR) − (0.022 × Na) was created. It had 90-day survival time 76.5 % for low risk group and 40.6 % for high risk group (p = 0.001) with ROC curve area 0.7 (95 % CI 0.599–0.796). The pediatric risk score such as MELD predicts the risk of liver transplantation waiting list mortality. Use of such scores in organ allocation in Iranian liver transplant unit may result in reduced waiting list mortality.
Literatur
Zurück zum Zitat Ben-Haim M, Carrniel M, Katz P, Shabtai E, Oren R, Nakache R (2006) Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality. Indian Med Assoc J 8(9):605–9 Ben-Haim M, Carrniel M, Katz P, Shabtai E, Oren R, Nakache R (2006) Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality. Indian Med Assoc J 8(9):605–9
Zurück zum Zitat Carey RG, Bucuvalas JC, Balistreri WF, Nick TG, Ryckman FR, Yazigi N (2010) Hyponatremia increases mortality in pediatric patients listed for liver transplantation. Pediatr Transplant 14(1):115–20CrossRefPubMed Carey RG, Bucuvalas JC, Balistreri WF, Nick TG, Ryckman FR, Yazigi N (2010) Hyponatremia increases mortality in pediatric patients listed for liver transplantation. Pediatr Transplant 14(1):115–20CrossRefPubMed
Zurück zum Zitat Dehghani SM, Gholami S, Bahador A, Nikeghbalian S, Salahi H, Imanieh MH et al (2007) Morbidity and mortality of children with chronic liver diseases who were listed for liver transplantation in Iran. Pediatr Transplant 11(1):21–3CrossRefPubMed Dehghani SM, Gholami S, Bahador A, Nikeghbalian S, Salahi H, Imanieh MH et al (2007) Morbidity and mortality of children with chronic liver diseases who were listed for liver transplantation in Iran. Pediatr Transplant 11(1):21–3CrossRefPubMed
Zurück zum Zitat Del Pino M, Cervio G, Dip M, Giannivelli S, Buamscha D, Ciocca M et al (2006) Mortality risk score in liver transplantation: changes over time in its predicting power. Pediatr Transplant 10(4):466–73CrossRefPubMed Del Pino M, Cervio G, Dip M, Giannivelli S, Buamscha D, Ciocca M et al (2006) Mortality risk score in liver transplantation: changes over time in its predicting power. Pediatr Transplant 10(4):466–73CrossRefPubMed
Zurück zum Zitat Fink MA, Berry SR, Gow PJ, Angus PW, Wang B-Z, Muralidharan V et al (2007) Risk factors for liver transplantation waiting list mortality. J Gastroenterol Hepatol 22(1):119–24CrossRefPubMed Fink MA, Berry SR, Gow PJ, Angus PW, Wang B-Z, Muralidharan V et al (2007) Risk factors for liver transplantation waiting list mortality. J Gastroenterol Hepatol 22(1):119–24CrossRefPubMed
Zurück zum Zitat Gridelli B, Spada M, Riva S, Maggiore G (2008) Liver transplantation. In: Kleinman RE, Goulet OJ, Mieli-Vergani G, Sanderson I, Sherman P, Shneider B (eds) Walker's pediatric gastrointestinal disease, 5th edn. Hamilton, BC Decker Inc, USA, p 1149 Gridelli B, Spada M, Riva S, Maggiore G (2008) Liver transplantation. In: Kleinman RE, Goulet OJ, Mieli-Vergani G, Sanderson I, Sherman P, Shneider B (eds) Walker's pediatric gastrointestinal disease, 5th edn. Hamilton, BC Decker Inc, USA, p 1149
Zurück zum Zitat McDiarmid SV, Anand R, Lindblad AS (2004) Studies of pediatric liver transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant 8(3):284–94CrossRefPubMed McDiarmid SV, Anand R, Lindblad AS (2004) Studies of pediatric liver transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant 8(3):284–94CrossRefPubMed
Zurück zum Zitat Porrett PM, Baranov E, ter Horst M (2015) Serum hypoalbuminemia predicts late mortality on the liver transplant waiting list. Transplantation 99(1):158–63CrossRefPubMed Porrett PM, Baranov E, ter Horst M (2015) Serum hypoalbuminemia predicts late mortality on the liver transplant waiting list. Transplantation 99(1):158–63CrossRefPubMed
Zurück zum Zitat Ryckman FC, Fisher RA, Pedersen SH, Balistreri WF (1992) Liver transplantation in children. Semin Pediatr Surg 1(2):162–72PubMed Ryckman FC, Fisher RA, Pedersen SH, Balistreri WF (1992) Liver transplantation in children. Semin Pediatr Surg 1(2):162–72PubMed
Zurück zum Zitat Šumskienė J, Kupčinskas L, Pundzius J, Šumskas L (2005) Prognostic factors for short and longterm survival in patients selected for liver transplantation. Medicina 41(1):39–46PubMed Šumskienė J, Kupčinskas L, Pundzius J, Šumskas L (2005) Prognostic factors for short and longterm survival in patients selected for liver transplantation. Medicina 41(1):39–46PubMed
Metadaten
Titel
Liver function, paraclinical tests, and mortality risk factors in pediatric liver transplant candidates
verfasst von
Naghi Dara
Seyed Mohsen Dehghani
Alireza Safarpour
Masood Sepehrimanesh
Publikationsdatum
01.01.2016
Verlag
Springer London
Erschienen in
Comparative Clinical Pathology / Ausgabe 1/2016
Print ISSN: 1618-5641
Elektronische ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-015-2168-y

Weitere Artikel der Ausgabe 1/2016

Comparative Clinical Pathology 1/2016 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …